London pre-open: October US jobs report may hold key to December FOMC
6th Nov 2015 07:47
(ShareCast News) - In Friday´s session all eyes will be trained on the latest US jobs report for October, which may hold the key to an interest rate hike - or not - at the 15-16 December meeting of the US Federal Open Market Committee. Is the outlook for the American economy so strong that beginning
Read moreLondon close: Copper prices weigh on Footsie despite dovish MPC
5th Nov 2015 16:36
(ShareCast News) - Equities ended near their worst levels of the day despite a dovish set of minutes from the Bank of England's last Monetary Policy Committee meeting, weighed down by a further drop in commodity prices. Following its meeting, the MPC said there were downside risks to growth
Read moreFTSE 100 movers: Anglo American falls to 16-year lows
5th Nov 2015 14:18
(ShareCast News) - The FTSE 100 was down for most of the day on Thursday, with the market going into the black briefly after the Bank of England kept interest rates unchanged. By mid-afternoon, the market was back into the red, down 22.58 points (0.35%) to 6,390.3 points. Anglo American was the big
Read moreLondon open: Investors anxious ahead of MPC's 'Super Thursday'
5th Nov 2015 08:30
(ShareCast News) - Investors in UK shares were anxious ahead of Thursday's meeting of the Monetary Policy Committee after remarks by US Federal Reserve chairwoman Janet Yellen on the previous day led traders to push up the odds of a December rate hike across the Pond. As of 0945 GMT the FTSE 100 was
Read moreAstraZeneca's third quarter profit hit by foreign exchange
5th Nov 2015 07:11
(ShareCast News) - AstraZeneca's third quarter revenues have been hit by foreign exchange woes, but the company has upgraded its revenue outlook for the year and beat expectations for earnings per share. The FTSE 100 pharmaceutical company posted its third quarter results to 30 September on Thursday
Read moreLondon pre-open: MPC, central banks in focus
5th Nov 2015 07:07
(ShareCast News) - Investors were anxious ahead of Thursday´s meeting of the Monetary Policy Committee given the more 'hawkish' tone adopted by US Federal Reserve chairwoman Janet Yellen on the previous day. The Footsie was being called to start the day 11 points above Wednesday´s close of 6,412.88
Read moreAstraZeneca's gout drug recommended by FDA committee
26th Oct 2015 07:18
(ShareCast News) - The US Food and Drug Administration's Arthritis Advisory Committee has recommended the approval of AstraZeneca's lesinurad tablets for the treatment of hyperuricemia associated with gout. The FTSE 100 drug company announced the decision on Monday. The committee recommended the dr
Read moreAstraZeneca slumps on Credit Suisse downgrade
20th Oct 2015 15:53
(ShareCast News) - Credit Suisse cut AstraZeneca to 'underperform' from 'neutral' and trimmed its price target to 4,000p from 4,320p. The bank said the downgrade reflected the weak overall score for the group in its 2016 PharmaValues Strategic analysis. "AZN scores poorly on net present value and s
Read moreFTSE 100 movers: Shire's schadenfreude as FDA holds up AstraZeneca
16th Oct 2015 14:03
(ShareCast News) - The FTSE 100 was up 28.77 points (0.45%) mid-afternoon Friday to 6,367.44 as hopes of further stimulus measures by the European Central Bank increase on the back of continued low Eurozone inflation figures. Shire PLC led the risers on the back of news from AstraZeneca that the US
Read moreLondon pre-open: Stocks set to rise sharply at start of trading
16th Oct 2015 07:38
(ShareCast News) - Stocks are expected to start the session comfortably higher thanks to the strong showing put in by Wall Street overnight. The Footsie is being called to rise by as much as 57 points to 6,338.67 at the start of trading. As of 07:24 the Shanghai Stock Exchange's Composite Index was
Read moreLondon open: Stocks drop as US trading closed for holiday
12th Oct 2015 08:36
(ShareCast News) - UK stocks dropped on Monday which will prove a quiet day for traders with US closed for a holiday and no major economic data releases. The FTSE opened down 25 points as gains in oil and mining stocks were offset by declines in banking and pharmaceuticals, led by Astrazeneca. The d
Read moreAstraZeneca completes divestment of Caprelsa cancer drug
7th Oct 2015 07:49
(ShareCast News) - AstraZeneca has finalised the divestment of cancer drug Caprelsa to Genzyme. The FTSE 100 company confirmed the news on Wednesday. Genzyme paid AstraZeneca $165m to acquire the global rights to sell and develop the drug, and will make further milestone payments of up to $135m. I
Read moreBroker tips: Henderson Group, AstraZeneca, IAG
14th Sep 2015 16:39
(ShareCast News) - Exane BNP Paribas took a look at UK asset managers, noting that their shares have sold off sharply, making for an enticing entry point. "Equity market volatility is a risk to inflows, but historically the impact has been temporary and flows into other asset classes do not suffer a
Read moreDeutsche Bank ups AstraZeneca to 'buy'; sees return to strong growth
14th Sep 2015 10:41
(ShareCast News) - Deutsche Bank upgraded AstraZeneca to 'buy' from 'hold' and raised its price target to 5,700p from 4,850p. The bank said it's increasingly confident in AstraZeneca's ability to deliver a return to strong growth from a base in 2017. "We have increased our outer year sales and earn
Read moreAstraZeneca buys Colorado manufacturing plant from Amgen
11th Sep 2015 08:02
(ShareCast News) - AstraZeneca has purchased a high-tech biologics bulk manufacturing facility from US-based Amgen for an undisclosed sum. The pharmaceuticals giant said the LakeCentre facility, located in Boulder, Colorado will increase manufacturing and production capacity to support the company's
Read more